Vector development for the expression of foreign proteins in the vaccine strain Brucella abortus S19

被引:27
作者
Comerci, DJ
Pollevick, GD
Vigliocco, AM
Frasch, ACC
Ugalde, RA
机构
[1] Univ Nacl Gen San Martin, Inst Invest Biotechnol, RA-1650 San Martin, Bueno Aires, Argentina
[2] Comis Nacl Energia Atom, Ctr Atom Ezeiza, Grp Invest Pecuarias, RA-1429 Buenos Aires, DF, Argentina
关键词
D O I
10.1128/IAI.66.8.3862-3866.1998
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A vector for the expression of foreign antigens in the vaccine strain Brucella abortus S19 was developed by using a DNA fragment containing the regulatory sequences and the signal peptide of the Brucella bcsp31 gene. This fragment was cloned in broad-host-range plasmid pBBR4MCS, resulting in plasmid pBEV. As a reporter protein, a repetitive antigen of Trypanosoma cruzi was used, The recombinant fusion protein is stably expressed and secreted into the Brucella periplasmic space, inducing a good antibody response against the T. cruzi antigen. The expression of the repetitive antigen in Brucella neither altered its growth pattern nor generated a toxic or lethal effect during experimental infection, The application of this strategy for the generation of live recombinant vaccines and the tagging of B. abortus S19 vaccine is discussed. This is the first time that a recombinant protein has been expressed in the periplasm of brucellae.
引用
收藏
页码:3862 / 3866
页数:5
相关论文
共 25 条
  • [1] CONSERVATION OF ANTIGENICITY IN A 31-KDA BRUCELLA PROTEIN
    BRICKER, BJ
    TABATABAI, LB
    DEYOE, BL
    MAYFIELD, JE
    [J]. VETERINARY MICROBIOLOGY, 1988, 18 (3-4) : 313 - 325
  • [2] ANTIGENS OF BRUCELLA-ABORTUS S19 IMMUNODOMINANT FOR BOVINE LYMPHOCYTES AS IDENTIFIED BY ONE-DIMENSIONAL AND 2-DIMENSIONAL CELLULAR IMMUNOBLOTTING
    BROOKSWORRELL, BM
    SPLITTER, GA
    [J]. INFECTION AND IMMUNITY, 1992, 60 (06) : 2459 - 2464
  • [3] The repetitive domain of Trypanosoma cruzi trans-sialidase enhances the immune response against the catalytic domain
    Buscaglia, CA
    Campetella, O
    Leguizamón, MS
    Frasch, ACC
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (02) : 431 - 436
  • [4] Brucellosis: An overview
    Corbel, MJ
    [J]. EMERGING INFECTIOUS DISEASES, 1997, 3 (02) : 213 - 221
  • [5] PROTECTIVE ANTIGENS IN BRUCELLOSIS
    DUBRAY, G
    [J]. ANNALES DE L INSTITUT PASTEUR-MICROBIOLOGIE, 1987, 138 (01): : 84 - 87
  • [6] IN-VIVO AND IN-VITRO STABILITY OF THE BROAD-HOST-RANGE CLONING VECTOR PBBR1MCS IN 6 BRUCELLA SPECIES
    ELZER, PH
    KOVACH, ME
    PHILLIPS, RW
    ROBERTSON, GT
    PETERSON, KM
    ROOF, RM
    [J]. PLASMID, 1995, 33 (01) : 51 - 57
  • [7] BRUCELLA-ABORTUS CONJUGATED WITH A GP120 OR V3 LOOP PEPTIDE DERIVED FROM HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1 INDUCES NEUTRALIZING ANTI-HIV ANTIBODIES, AND THE V3 B-ABORTUS CONJUGATE IS EFFECTIVE EVEN AFTER CD4(+) T-CELL DEPLETION
    GOLDING, B
    INMAN, J
    HIGHET, P
    BLACKBURN, R
    MANISCHEWITZ, J
    BLYVEIS, N
    ANGUS, RD
    GOLDING, H
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (06) : 3299 - 3307
  • [8] DELETION OF THE BCSP31 GENE OF BRUCELLA-ABORTUS BY REPLACEMENT
    HALLING, SM
    DETILLEUX, PG
    TATUM, FM
    JUDGE, BA
    MAYFIELD, JE
    [J]. INFECTION AND IMMUNITY, 1991, 59 (11) : 3863 - 3868
  • [9] HIGH-EFFICIENCY TRANSFORMATION OF ESCHERICHIA-COLI WITH PLASMIDS
    INOUE, H
    NOJIMA, H
    OKAYAMA, H
    [J]. GENE, 1990, 96 (01) : 23 - 28
  • [10] KOVACH ME, 1994, BIOTECHNIQUES, V16, P800